Bank OZK’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-12,598
| Closed | -$221K | – | 143 |
|
|
2017
Q3 | $221K | Sell |
12,598
-2,030
| -14% | -$35.6K | 0.09% | 119 |
|
|
2017
Q2 | $486K | Sell |
14,628
-4,531
| -24% | -$151K | 0.17% | 93 |
|
|
2017
Q1 | $614K | Sell |
19,159
-1,635
| -8% | -$52.4K | 0.2% | 80 |
|
|
2016
Q4 | $754K | Sell |
20,794
-3,155
| -13% | -$114K | 0.25% | 62 |
|
|
2016
Q3 | $1.1M | Sell |
23,949
-76
| -0.3% | -$3.5K | 0.4% | 43 |
|
|
2016
Q2 | $1.21M | Buy |
24,025
+5,740
| +31% | +$288K | 0.44% | 38 |
|
|
2016
Q1 | $979K | Buy |
18,285
+165
| +0.9% | +$8.83K | 0.36% | 43 |
|
|
2015
Q4 | $1.19M | Buy |
18,120
+160
| +0.9% | +$10.5K | 0.42% | 34 |
|
|
2015
Q3 | $1.01M | Buy |
17,960
+985
| +6% | +$55.6K | 0.39% | 36 |
|
|
2015
Q2 | $1M | Buy |
16,975
+65
| +0.4% | +$3.84K | 0.35% | 40 |
|
|
2015
Q1 | $1.05M | Buy |
16,910
+1,585
| +10% | +$98.8K | 0.38% | 36 |
|
|
2014
Q4 | $881K | Buy |
15,325
+1,200
| +8% | +$69K | 0.3% | 45 |
|
|
2014
Q3 | $759K | Buy |
14,125
+1,715
| +14% | +$92.2K | 0.28% | 48 |
|
|
2014
Q2 | $650K | Buy |
12,410
+1,895
| +18% | +$99.3K | 0.23% | 60 |
|
|
2014
Q1 | $555K | Buy |
10,515
+2,150
| +26% | +$113K | 0.2% | 63 |
|
|
2013
Q4 | $335K | Buy |
8,365
+1,160
| +16% | +$46.5K | 0.13% | 87 |
|
|
2013
Q3 | $272K | Buy |
7,205
+50
| +0.7% | +$1.89K | 0.12% | 89 |
|
|
2013
Q2 | $280K | Buy |
+7,155
| New | +$280K | 0.21% | 41 |
|